Clinical Trials Directory

Trials / Conditions / Large Cell Lung Cancer

Large Cell Lung Cancer

21 registered clinical trials studyying Large Cell Lung Cancer — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingProspective Data Collection Initiative on Thoracic Malignancies
NCT06996249
Dutch Society of Physicians for Pulmonology and Tuberculosis—
WithdrawnCISH Inactivated TILs in the Treatment of NSCLC
NCT05566223
Intima Bioscience, Inc.Phase 1 / Phase 2
CompletedEvaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Ca
NCT03305133
Groupe Francais De Pneumo-Cancerologie—
CompletedIcotinib for Completed Resected IB NSCLC With EGFR Mutation
NCT02264210
Sun Yat-sen UniversityPhase 2
CompletedRadiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell
NCT01958372
Barbara Ann Karmanos Cancer InstitutePhase 1
TerminatedS1300: Pemetrexed Disodium With or Without Crizotinib in Treating Patients With Stage IV Non-Small Cell Lung C
NCT02134912
SWOG Cancer Research NetworkPhase 2
WithdrawnPhase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC
NCT02059967
Virginia Commonwealth UniversityPhase 1
Active Not RecruitingImage-Guided Hypofractionated Radiation Therapy With Stereotactic Body Radiation Therapy Boost and Combination
NCT01345851
Jonsson Comprehensive Cancer CenterN/A
CompletedDocetaxel, Cisplatin, Pegfilgrastim, and Erlotinib Hydrochloride in Treating Patients With Stage IIIB or Stage
NCT01557959
Wake Forest University Health SciencesPhase 2
CompletedS0536: Cetuximab, Paclitaxel, Carboplatin, and Bevacizumab in Treating Patients With Advanced Non-Small Cell L
NCT00368992
National Cancer Institute (NCI)Phase 2
TerminatedBevacizumab, Paclitaxel, Carboplatin, and Radiation Therapy to the Chest in Treating Patients With Locally Adv
NCT00369551
National Cancer Institute (NCI)Phase 1
CompletedDocetaxel With Either Cetuximab or Bortezomib as First-Line Therapy in Treating Patients With Stage III or Sta
NCT00118183
National Cancer Institute (NCI)Phase 2
CompletedS0341: Erlotinib in Treating Patients With Advanced Primary Non-Small Cell Lung Cancer
NCT00087412
National Cancer Institute (NCI)Phase 2
CompletedPhotodynamic Therapy in Treating Patients With Lung Cancer
NCT01668823
Roswell Park Cancer InstitutePhase 1
CompletedGefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Remov
NCT00049543
National Cancer Institute (NCI)Phase 3
CompletedCombination Chemotherapy With or Without Bevacizumab in Treating Patients With Advanced, Metastatic, or Recurr
NCT00021060
National Cancer Institute (NCI)Phase 2 / Phase 3
CompletedCombination Chemotherapy, Radiation Therapy, and Gefitinib in Treating Patients With Stage III Non-Small Cell
NCT00040794
National Cancer Institute (NCI)Phase 2
TerminatedErlotinib and Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Inoperable Stage III N
NCT00042835
National Cancer Institute (NCI)Phase 1
CompletedCombination Chemotherapy and Radiation Therapy With or Without Gefitinib in Treating Patients With Stage III N
NCT00020709
National Cancer Institute (NCI)Phase 3
CompletedCombination Chemotherapy Plus Radiation Therapy With or Without AE-941 in Treating Patients With Stage III Non
NCT00005838
National Cancer Institute (NCI)Phase 3
CompletedSurgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer
NCT00002852
National Cancer Institute (NCI)Phase 3